Qi-cai Wu

Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Building and validating a machine learning model to predict coronary heart disease risk based on non-invasive indicators.

Building and validating a machine learning model to predict coronary heart disease risk based on non-invasive indicators.

Journal: Computer methods and programs in biomedicine
Published: April 21, 2025

SETD2 drives METTL14-mediated m6A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.

SETD2 drives METTL14-mediated m6A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.

Journal: Cellular and molecular life sciences : CMLS
Published: March 02, 2025

Lactate regulates pathological cardiac hypertrophy via histone lactylation modification.

Lactate regulates pathological cardiac hypertrophy via histone lactylation modification.

Journal: Journal of cellular and molecular medicine
Published: November 06, 2023

Role of histone lactylation interference RNA m6A modification and immune microenvironment homeostasis in pulmonary arterial hypertension.

Role of histone lactylation interference RNA m6A modification and immune microenvironment homeostasis in pulmonary arterial hypertension.

Journal: Frontiers in cell and developmental biology
Published: July 28, 2023

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation.

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: February 19, 2020

SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.

SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.

Journal: Aging
Published: February 10, 2020

Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

Journal: Journal of cellular and molecular medicine
Published: September 24, 2019

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function.

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function.

Journal: Journal of cellular and molecular medicine
Published: August 11, 2019

NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.

NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.

Journal: Clinical science (London, England : 1979)
Published: February 16, 2019

Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.

Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.

Journal: Journal of cellular physiology
Published: August 03, 2018

NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.

NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.

Journal: Journal of cellular and molecular medicine
Published: July 05, 2018

Notch1 provides myocardial protection by improving mitochondrial quality control.

Notch1 provides myocardial protection by improving mitochondrial quality control.

Journal: Journal of cellular physiology
Published: May 25, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026